catechin has been researched along with Thyroid Carcinoma, Anaplastic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biray Avci, C; Birden, N; Goker Bagca, B; Gunduz, C; Ozates, NP; Sabour Takanlou, L; Sabour Takanlou, M; Selvi Gunel, N | 1 |
| Allegri, L; Baldan, F; Damante, G; Filetti, S; Mio, C; Rosignolo, F | 1 |
2 other study(ies) available for catechin and Thyroid Carcinoma, Anaplastic
| Article | Year |
|---|---|
The effects of Epigallocatechin-3-gallate and Dabrafenib combination on apoptosis and the genes involved in epigenetic events in anaplastic thyroid cancer cells.
Topics: Apoptosis; Catechin; Cell Line, Tumor; Epigenesis, Genetic; Humans; Imidazoles; Oximes; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2022 |
Effects of nutraceuticals on anaplastic thyroid cancer cells.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Catechin; Cell Differentiation; Cell Growth Processes; Cell Line, Tumor; Curcumin; Dietary Supplements; Genistein; Humans; MicroRNAs; Resveratrol; Stilbenes; Thyroid Carcinoma, Anaplastic; Thyroid Neoplasms | 2018 |